The Hong Kong Polytechnic University (posters, Facebook, WhatsApp groups etc.)
Hong Kong, China
NCT Number: NCT06497582
The proposed study will be a 3-arm, parallel-group randomized controlled trial on the effects of self-acupressure and Zhan-Zhuang for alleviating pain, fatigue, and sleep disturbance in breast cancer survivors. Subjects will include 54 breast cancer survivors who have experienced a moderate level of pain, fatigue and sleep disturbance. All eligible subjects will be randomized into one of the three groups in a 1:1:1 ratio: Zhan Zhuang group, or self-acupressure group, or wait list control group. Subjects in the Zhan-Zhuang group will receive up to 8 weeks of the intervention consisting of a training course over two weeks followed by self-practice for 6 weeks. Those in the self-acupressure group will attend an acupressure training course for two weeks and then, will be asked to practice self-acupressure for 6 weeks. The wait list control group will be provided with delayed self-acupressure or Zhan Zhuang at the end of the study. Outcome assessment will be conducted at baseline, week 8 (post-intervention) and week 12 (4 week follow-up). Primary outcomes include pain, fatigue and sleep disturbance. Secondary outcomes include psychological distress and health-related quality of life. Qualitative data will be collected from selected participants who have received the intervention.
Looking for future studies?
Notify Me18 year–70 year
Female
Interventional
Not applicable
Hong Kong, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
zhan-zhuang as a fundamental type of qigong
Self-acupressure as a common type of traditional Chinese medicine therapies
Time frame: Baseline, after 8 weeks, after 12 weeks
Pain will be measured by the traditional Chinese version of the Brief Pain Inventory. The questionnaire has 9 items assessing pain severity and interference with activities. It is rated using a 0-10 scale (0= no pain and no interference, 10=pain as bad as one can imagine and interferes completely).
Time frame: Baseline, after 8 weeks, after 12 weeks
Fatigue will be measured by the traditional Chinese version of the Brief Fatigue Inventory. The questionnaire has 9 items assessing pain severity and interference with activities. It is rated using a 0-10 scale (0= no pain and no interference, 10=pain as bad as one can imagine and interferes completely).
Time frame: Baseline, after 8 weeks, after 12 weeks
Sleep disturbance will be measured by the 19-item traditional Chinese version of the Pittsburgh Sleep Quality Index. The questionnaire consists of seven domains using 19 items: overall sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, day dysfunction due to sleepiness, and use of sleeping medication. The global score is calculated by summing up the scores of seven domains, with a higher score indicating greater sleep disturbance.
Time frame: Baseline, after 8 weeks, after 12 weeks
Psychological distress will be measured by the 4-item traditional Chinese version of the Patient Health Questionnaire-4. The questionnaire has two subscales, with the 2-item General Anxiety Disorder screener for assessing anxiety and the 2-item Patient Health Questionnaire for assessing depression. Each item is rated on a 4-point scale ranging from 0 (not at all) to 3 (nearly every day) and the subscale scale ranges from 0 to 6.
Time frame: Baseline, after 8 weeks, after 12 weeks
Health-related quality of life will be measured by the 27-item Traditional Chinese version of the Functional Assessment of Cancer Therapy scale. The questionnaire is a 27-item cancer-specific measure and consists of four domains: physical, social/family, emotional, and functional. Scores of items in specific domains will be created to produce subscale scores and subsequently added to produce a total scale. A higher score reflects better health-related quality of life
Time frame: After 12 weeks
Eligibility rate
Time frame: After 12 weeks
Recruitment rate
Time frame: After 12 weeks
Retention rate
Time frame: After 12 weeks
Reasons for withdrawal from the study as collected from participants through calling them
Time frame: After 8 weeks of the intervention
Measured by the 10-item adapted Theoretical Framework of Acceptability Questionnaire (1=disagree, 5=agree). A higher score indicates higher acceptability
Time frame: After 8 weeks of the intervention
Qualitative in-depth interviews
The Hong Kong Polytechnic University
Other
Self-acupressure and Zhan Zhuang for Pain, Fatigue, and Sleep Disturbance in Breast Cancer Survivors: A Pilot Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06540612
Behavior, Breast Cancer Female
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT03618017
Breast Cancer Female, Breast Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT03575624
Breast Cancer Female, Survivorship
Milwaukee, Wisconsin, United States
View Trial DetailsNCT05975437
Breast Cancer, Breast Cancer Female
Apeldoorn, Gelderland, Netherlands
View Trial Details